Indoco Remedies Closes Trading Window for Q2 FY27 Results

Indoco Remedies Ltd has announced the closure of its trading window for dealing in equity shares. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct. The window will be shut from July 1, 2026, until 48 hours after the declaration of the Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026. During this period, all designated persons and their immediate relatives are prohibited from trading in the company's shares. The date for the board meeting to approve these financial results will be communicated separately.